Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumors worldwide and effective therapies, including molecular therapy, remain elusive. Our previous work demonstrates that oncogenic KIAA0101 transcript variant (tv) 1 promotes HCC development and might be a HCC therapeutic target. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lijuan, Liu, Youyi, Chen, Xiaobei, Wang, Miao, Zhou, Yan, Zhou, Ping, Li, Wenxin, Zhu, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546456/
https://www.ncbi.nlm.nih.gov/pubmed/28410205
http://dx.doi.org/10.18632/oncotarget.16702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546456/
https://www.ncbi.nlm.nih.gov/pubmed/28410205
http://dx.doi.org/10.18632/oncotarget.16702

Ejemplares similares